Tetramide may be available in the countries listed below.
Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Tetramide in the following countries:
International Drug Name Search
Ketamav may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Ketamav in the following countries:
International Drug Name Search
Tri-Profen may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Tri-Profen in the following countries:
International Drug Name Search
Metasedin may be available in the countries listed below.
Methadone hydrochloride (a derivative of Methadone) is reported as an ingredient of Metasedin in the following countries:
International Drug Name Search
Youfenac may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Youfenac in the following countries:
International Drug Name Search
Aminofilin may be available in the countries listed below.
Aminophylline is reported as an ingredient of Aminofilin in the following countries:
International Drug Name Search
Rec.INN
N01BB08
0023964-58-1
C13-H20-N2-O3-S
284
Anesthetic, local
2-Thiophenecarboxylic acid, 4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-, methyl ester
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Flunifen may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Flunixin meglumine (a derivative of Flunixin) is reported as an ingredient of Flunifen in the following countries:
International Drug Name Search
Generic Name: rimabotulinumtoxinB (Myobloc) (RYE ma BOT ue LYE num TOX in B)
Brand Names: Myobloc
RimabotulinumtoxinB (Myobloc), also called botulinum toxin type B, is made from the bacteria that causes botulism. Botulinum toxin blocks nerve activity in the muscles, causing a temporary reduction in muscle activity.
Myobloc is used to treat cervical dystonia (severe spasms in the neck muscles).
Myobloc may also be used for other purposes not listed in this medication guide.
The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
Using this medication more often than prescribed will not make it more effective and may result in serious side effects.
Before receiving a botulinum toxin injection, tell your doctor if you have ALS ( Lou Gehrig's disease), myasthenia gravis, or Lambert-Eaton syndrome.
The effects of a botulinum toxin injection are temporary. Your symptoms may return completely within 3 months after an injection. After repeat injections, it may take less and less time before your symptoms return, especially if your body develops antibodies to the botulinum toxin.
If you have any of these other conditions, you may need a dose adjustment or special tests:
amyotrophic lateral sclerosis (ALS, or "Lou Gehrig's disease");
myasthenia gravis;
Lambert-Eaton syndrome;
a breathing problem such as asthma or emphysema;
problems with swallowing;
bleeding problems;
if you are planning to have surgery; or
if you have ever received other botulinum toxin injections such as Botox or Dysport (especially in the last 4 months).
Myobloc is made using human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.
This medication is injected into a muscle. A doctor, nurse, or other healthcare provider will give you this injection. Myobloc injections should be spaced at least 3 months apart.
Your injection may be given into more than one area at a time, depending on the condition being treated.
Using this medication more often than prescribed will not make it more effective and may result in serious side effects.
Since botulinum toxin has a temporary effect and is given at widely spaced intervals, missing a dose is not likely to be harmful.
Overdose symptoms may not appear right away, but can include muscle weakness, trouble swallowing, and weak or shallow breathing.
The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
trouble breathing, talking, or swallowing;
hoarse voice, drooping eyelids;
unusual or severe muscle weakness (especially in a body area that was not injected with the medication);
loss of bladder control;
problems with vision; or
chest pain.
Less serious side effects may include:
pain or muscle weakness near where the medicine was injected;
headache, joint or back pain;
dry mouth, nausea, upset stomach;
fever, cough, sore throat, flu symptoms;
pain or stiffness in your neck; or
dizziness, drowsiness, anxiety.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Cervical Dystonia:
Initial: The dose should be individualized based on the patient's head and neck position, localization of pain, muscle hypertrophy, patient response, and adverse event history.
Patients with a prior history of tolerating botulinum toxin injections: 2500 to 5000 units (0.5 to 1.0 mL) divided among affected muscles.
Patients with no history of botulinum toxin type B: use should be at a lower dose, with subsequent dosing based on individual response.
Clinical improvement generally begins within the first two weeks after injection with studies showing the duration of effect to be between 12 and 16 weeks at doses of 5000 units or 10,000 units.
Usual Adult Dose for Hyperhidrosis:
One method being used:
Initial: 2880 units per axilla intradermally for a total dose of 5760 units.
Dilute 5000 unit vial with 1.0 mL of saline in the vial. This dilution technique, when performed in the vial, yields 288 units per 0.1 mL of solution due to the slight overfill in the vial. With this dilution, inject 20 injections of 0.05 mL per axilla may be administered (with an approximate depth of 2 to 3 millimeters), resulting in a total dose of 2880 units per axilla. Injections should be scattered approximately every 2 square centimeters. If injection sites are marked in ink do not inject directly through the ink mark (to avoid a permanent tattoo mark).
Usual Adult Dose for Glabellar Lines:
For glabellar lines and other facial wrinkles: 0.1 mL (500 units) intradermally.
Usual Pediatric Dose for Cervical Dystonia:
The safety and efficacy of botulinum toxin type B for treatment of strabismus in children less than 12 years have not been established.
Initial: The dosage of botulinum toxin type B for the treatment of cervical dystonia should be individualized based on the patient's head and neck position, localization of pain, muscle hypertrophy, patient response, and adverse event history.
Patients with a prior history of tolerating botulinum toxin injections: 2500 to 5000 units (0.5 to 1.0 mL) intramuscularly divided among affected muscles.
Patients with no history of botulinum toxin type B: use should be at a lower dose, with subsequent dosing based on individual response.
Clinical improvement generally begins within the first two weeks after injection with studies showing the duration of effect to be between 12 and 16 weeks at doses of 5000 units or 10,000 units.
Usual Pediatric Dose for Hyperhidrosis:
One method being used:
Initial: 2880 units per axilla intradermally for a total dose of 5760 units.
Dilute 5000 unit vial with 1.0 mL of saline in the vial. This dilution technique, when performed in the vial, yields 288 units per 0.1 mL of solution due to the slight overfill in the vial. With this dilution, inject 20 injections of 0.05 mL per axilla may be administered (with an approximate depth of 2 to 3 millimeters), resulting in a total dose of 2880 units per axilla. Injections should be scattered approximately every 2 square centimeters. If injection sites are marked in ink do not inject directly through the ink mark (to avoid a permanent tattoo mark).
Usual Pediatric Dose for Glabellar Lines:
The safety and efficacy of botulinum toxin type B for treatment of strabismus in children less than 12 years have not been established.
For glabellar lines and other facial wrinkles: 0.1 mL (500 units) intradermally.
Tell your doctor about all other medicines you use, especially:
an antibiotic such as amikacin (Amikin), gentamicin (Garamycin), kanamycin (Kantrex), neomycin (Mycifradin, Neo-Fradin, Neo-Tab), paromomycin (Humatin, Paromycin), streptomycin, tobramycin (Nebcin, Tobi).
This list is not complete and other drugs may interact with Myobloc. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: botulinum toxin type B side effects (in more detail)
Generic Name: diclofenac ophthalmic (dye KLOE fen ak off THAL mik)
Brand Names: Voltaren Ophthalmic
Diclofenac is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Diclofenac works by reducing hormones that cause inflammation and pain in the body.
Diclofenac ophthalmic may also be used for purposes not listed in this medication guide.
Before using diclofenac ophthalmic, tell your doctor if you are allergic to any medications, or if you have a bleeding or blood-clotting disorder, diabetes, arthritis, glaucoma, dry eye syndrome, or if you have had other recent eye surgeries.
Tell your doctor about all other medications you use, especially a blood thinner such as warfarin (Coumadin, Jantoven).
Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label. Using the medication for longer than prescribed may increase the risk of serious side effects on your eyes.
To make sure you can safely use diclofenac ophthalmic, tell your doctor if you have any of these other conditions:
a bleeding or blood-clotting disorder;
diabetes;
arthritis;
glaucoma;
dry eye syndrome; or
if you have had other recent eye surgeries.
Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Diclofenac ophthalmic is usually given 24 hours before cataract surgery, and continued for 3 to 14 days after surgery. Using the medication for longer than prescribed may increase the risk of serious side effects on your eyes.
To apply the eye drops:
Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.
Use the eye drops only in the eye you are having surgery on.
Use only the number of drops your doctor has prescribed.
Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct.
Do not use the eye drops if the liquid has changed colors or has particles in it. Call your doctor for a new prescription.
Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.
Do not use other eye medications during treatment with diclofenac ophthalmic unless your doctor tells you to.
severe burning, stinging, or itching of your eyes;
eye pain, redness, or excessive watering;
vision changes, increased sensitivity to light;
white patches on your eyes;
crusting or drainage of your eyes; or
dizziness, stomach pain, vomiting, weakness, fever, chills, or flu symptoms (can occur if the medicine is absorbed into your bloodstream).
Less serious side effects may include:
mild burning, stinging, or itching of your eyes;
swollen or puffy eyelids;
nausea, vomiting, stomach pain;
weakness, fever or chills;
headache;
sleep problems (insomnia); or
runny nose.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Postoperative Ocular Inflammation:
1 drop to the affected eye(s) 4 times a day beginning 24 hours after cataract surgery and continuing throughout the first 2 weeks of the postoperative period. In some patients, treatment has been continued for 6 weeks or longer.
Usual Adult Dose for Inhibition of Intraoperative Miosis:
1 to 2 drops to the affected eye(s) 4 times a day for 3 days prior to surgery. 1 to 2 drops to the affected eye(s) every 15 minutes for 4 doses 1 hour before surgery.
1 drop to the affected eye(s) 15 minutes after surgery and continued 4 times daily starting 4 to 6 hours after surgery for 3 days as needed.
Usual Adult Dose for Corneal Ulcers:
1 drop to the affected eye(s) 4 to 5 times a day.
Usual Adult Dose for Keratoconjunctivitis:
1 drop to the affected eye(s) 4 to 5 times a day.
Usual Adult Dose for Conjunctivitis:
1 drop to the affected eye(s) 4 to 5 times a day.
Tell your doctor about all other medications you use, especially a blood thinner such as warfarin (Coumadin, Jantoven).
There may be other drugs that can interact with diclofenac ophthalmic. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Tofen may be available in the countries listed below.
Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Tofen in the following countries:
International Drug Name Search
